NDAORALTABLET, EXTENDED RELEASEPriority Review
Approved
Apr 2010
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
3
Mechanism of Action
receptor, although it can bind to other opioid receptors at higher doses. The principal therapeutic action of oxycodone is analgesia. Like all full opioid agonists, there is no ceiling effect to analgesia for oxycodone. Clinically, dosage is titrated to provide adequate analgesia and may be limited…
Clinical Trials (3)
A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain
Started Jun 2012
410 enrolled
Chronic PainLow Back PainAnalgesia
Pharmacokinetics Study of ALO-02 and OxyContin
Started Mar 2012
13 enrolled
Management of Moderate to Severe Pain
Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain
Started Dec 2010
395 enrolled
Chronic Noncancer Pain
Loss of Exclusivity
LOE Date
Mar 29, 2030
49 months away
Patent Expiry
Mar 29, 2030
Company
Purdue Pharma
CT - Stamford